Publications by authors named "Romi Gupta"

Claim this Profile
A
ATAD2 drives melanoma growth and progression and inhibits ferroptosis.
Ashok Mari, Kevin Graciano, Raj Kumar, Emily Giles, Patrick T Ball, Romi Gupta

EMBO Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-β1 suppression.
Suresh Chava, Suresh Bugide, Parmanand Malvi, Kelly D DeMarco, Boyang Ma, Romi Gupta

EMBO Mol Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the potential link between ADHD, anxiety, autism, and cancer risk.
Shreya Wajapeyee, Kristina Ford, Romi Gupta

Front Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mA-driven transcriptomic rewiring in tumor immune surveillance.
Parmanand Malvi, Patrick Ball, Romi Gupta, Narendra Wajapeyee

J Immunother Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PDE7A inhibition suppresses triple-negative breast cancer by attenuating de novo pyrimidine biosynthesis.
Parmanand Malvi, Suresh Bugide, Roshan Dutta, Kiran Kumar Reddi, Yvonne J K Edwards, Romi Gupta

Cell Rep Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the therapeutic use and outcome of antibody-drug conjugates in ovarian cancer treatment.
Revu V L Narayana, Romi Gupta

Oncogene· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotyping as Part of Routine Clinical Care-The Outcomes for a Large Paediatric Vascular Anomaly Cohort.
Sinead O'Sullivan, Maria Shilova, Angharad Webb, Glenn Francis, Jeremy Robertson, Romi Das Gupta

Am J Med Genet A· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune evasion in ovarian cancer: implications for immunotherapy and emerging treatments.
Romi Gupta, Raj Kumar, Courtney A Penn, Narendra Wajapeyee

Trends Immunol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus statement: support for supervisors of surgical training in Australia and Aotearoa New Zealand.
Deborah Paltridge, Jenepher Martin, James Churchill, Richard Grills, Benjamin Loveday, Romi Das Gupta

ANZ J Surg· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic regulation of NKG2D ligand and the rise of NK cell-based immunotherapy for cancer treatment.
Raj Kumar, Romi Gupta

Front Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IκBα kinase inhibitor BAY 11-7082 promotes anti-tumor effect in RAS-driven cancers.
Praveen Guruvaiah, Romi Gupta

J Transl Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerability.
Kiran Kumar Reddi, Suresh Chava, Siva Chander Chabattula, Yvonne J K Edwards, Kamaljeet Singh, Romi Gupta

Cell Death Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roles and therapeutic targeting of ceramide metabolism in cancer.
Narendra Wajapeyee, Teresa Chiyanne Beamon, Romi Gupta

Mol Metab· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK inhibitors suppress HCC and synergize with anti-PD-1 therapy and ABT-263 in preclinical models.
Suresh Bugide, Dhana Sekhar Reddy, Parmanand Malvi, Romi Gupta, Narendra Wajapeyee

iScience· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway by regulating MSK1 and PPP2R2B.
Parmanand Malvi, Suresh Chava, Guoping Cai, Kai Hu, Lihua Julie Zhu, Romi Gupta

Cell Rep Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE.
Praveen Guruvaiah, Suresh Chava, Chiao-Wang Sun, Nirupama Singh, Courtney A Penn, Romi Gupta

Cell Death Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer.
Suresh Bugide, Yvonne J K Edwards, Romi Gupta, Michael R Green, Narendra Wajapeyee

Proc Natl Acad Sci U S A· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress.
Roshan Dutta, Praveen Guruvaiah, Kiran Kumar Reddi, Suresh Bugide, Dhana Sekhar Reddy Bandi, Romi Gupta

NAR Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-targeting of specific epigenetic regulators in combination with CDC7 potently inhibit melanoma growth.
Suresh Chava, Suresh Bugide, Parmanand Malvi, Romi Gupta

iScience· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor-resistant pancreatic ductal adenocarcinoma.
Parmanand Malvi, Vipin Rawat, Romi Gupta, Narendra Wajapeyee

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in the Transcriptome and Chromatin Landscape in BRAFi-Resistant Melanoma Cells.
Kiran Kumar Reddi, Praveen Guruvaiah, Yvonne J K Edwards, Romi Gupta

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional determinants of cancer immunotherapy response and resistance.
Romi Gupta, Amitkumar Mehta, Narendra Wajapeyee

Trends Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Betacellulin promotes tumor development and EGFR mutant lung cancer growth by stimulating the EGFR pathway and suppressing apoptosis.
Suresh Chava, Suresh Bugide, Xuchen Zhang, Romi Gupta, Narendra Wajapeyee

iScience· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic regulation and targeting of ECM for cancer therapy.
Romi Gupta

Am J Physiol Cell Physiol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The BRD9/7 Inhibitor TP-472 Blocks Melanoma Tumor Growth by Suppressing ECM-Mediated Oncogenic Signaling and Inducing Apoptosis.
Lawrence David Mason, Suresh Chava, Kiran Kumar Reddi, Romi Gupta

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis